CRISPR Therapeutics AG·4

Jul 17, 5:19 PM ET

George Simeon 4

4 · CRISPR Therapeutics AG · Filed Jul 17, 2025

Insider Transaction Report

Form 4
Period: 2025-07-16
Transactions
  • Purchase

    Common Shares

    2025-07-16$52.03/sh+22,319$1,161,258238,897 total(indirect: See Note 2)
  • Purchase

    Common Shares

    2025-07-16$52.03/sh+960,983$49,999,9451,730,179 total(indirect: See Note 3)
  • Purchase

    Common Shares

    2025-07-16$52.03/sh+6,510$338,71569,687 total(indirect: See Note 1)
Footnotes (3)
  • [F1]The Reporting Person is the sole managing member of SR One Capital Management, LLC ("SR One Capital Management"), which is the sole general partner of SR One Capital Partners II, LP ("SR One Partners II"). SR One Partners II is the sole general partner of SR One Capital Fund II Aggregator, LP ("SR One Fund II Aggregator"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), or otherwise of such portion of the securities held by SR One Fund II Aggregator in which the Reporting Person has no pecuniary interest.
  • [F2]The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital Opportunities Partners I, LP ("SR One Opportunities Partners I"). SR One Opportunities Partners I is the sole general partner of SR One Capital Opportunities Fund I, LP ("SR One Opportunities Fund I"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by SR One Opportunities Fund I in which the Reporting Person has no pecuniary interest.
  • [F3]The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital SMA Partners, LP ("SMA Partners"). SMA Partners is the sole general partner of AMZL, LP ("AMZL"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by AMZL in which the Reporting Person has no pecuniary interest.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4